Chapter 13 Organophosphate and carbamate poisoning

Handbook of Clinical Neurology

Volumn 91, Issue , 2008, Pages 401-432

  De Bleecker, Jan L ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; ORGANOPHOSPHORUS COMPOUND;

ANIMAL; ARTICLE; CHEMISTRY; CLASSIFICATION; HISTORY; HUMAN; INTOXICATION;

ANIMALS; ANTICONVULSANTS; CARBAMATES; CHOLINESTERASE INHIBITORS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; POISONING;

EID: 66049091193     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)01513-8     Document Type: Review

References (265)

1. Abou-Donia M.B. Delayed neurotoxicity of phenylphosphonothioate esters. Science 205 (1979) 713-715
2. Abou-Donia M.B. Organophosphorus ester-induced delayed neurotoxicity. Ann Rev Pharmacol Toxicol 21 (1981) 511-548
3. Abou-Donia M.B., and Lapadula D.M. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type 1 and type 2. Ann Rev Pharmacol Toxicol 30 (1990) 405-440
4. Abou-Donia M.B., Wilmarth K.R., Jensen K.F., et al. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health 48 (1996) 35-56
5. Abou-Donia M.B., Goldstein L.B., Jones K.H., et al. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicol Sci 60 (2001) 305-314
6. Ahlgren J.D., Manz H.J., and Harvey J.C. Myopathy of chronic organophosphate poisoning. A clinical entity?. South Med J 72 (1979) 555-563
7. Albuquerque E.X., Akaike A., Shaw K., et al. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex. Fundam Appl Toxicol 4 (1984) S27-S33
8. Albuquerque E.X., Deshpande S.S., Kawabuchi M., et al. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning. Fundam Appl Toxicol 5 (1985) S182-S203
9. Albuquerque E.X., Allen C.N., Aracava Y., et al. Activation and inhibition of the nicotinic receptor: actions of physostigmine, pyridostigmine and meproadifen. In: Hanin I. (Ed). Dynamics of Cholinergic Function.teratology (1986), PlenumPress, New York 677-695
10. Albuquerque E.X., Aracava Y., Idriss M., et al. Activation and blockade of the nicotinic and glutamatergic synapses by reversible and irreversible cholinesterase inhibitors. In: Dun N.J., and Perlman E. (Eds). Neurobiology of Acetylcholine (1987), Plenum, New York 301-328
11. Albuquerque E.X., Alkondon M., Deshpande S.S., et al. Molecular interactions of organophosphates (OPs), oximes and carbamates at nicotinic receptors. In: Narahashi T., and Chambers E. (Eds). Insecticide Action: From Molecule to Organism (1988), Plenum, New York 33-53
12. Aldridge J.E., Seidler F.J., Meyer A., et al. Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ Health Perspect 111 (2003) 1736-1743
13. Aldridge W.N., and Reiner E. Enzyme Inhibitors as Substrates. Interactions of Esterases with Esters of Organophosphorus and Carbamic Acids (1972) North Holland, New York
14. Anderson D.R., Harris L.W., Lennox W.J., et al. Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure. Drug Chem Toxicol 14 (1991) 1-19
15. Ariëns A.T., Meeter E., Wolthuis O.L., et al. Reversible necrosis at the end-plate region in striated muscles of the rat poisoned with cholinesterase inhibitors. Experientia 25 (1969) 57-59
16. Aring C.D. The systemic nervous affinita of triorthocresylphosphate. Brain 65 (1942) 34-47
17. Ashon Y., Radic Z., Tsigelny I., et al. Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes. J Biol Chem 270 (1995) 6370-6380
18. Augustinsson K.B. Determination of activity of cholinesterases. Methods Biochem Anal 19 (1971) 217-273
19. Averbook B.J., and Anderson R.J. Electrophysiological changes associated with chronic administration of organophosphates. Arch Toxicol 52 (1983) 167-172
20. Aygun D., Onar M.K., and Alintop B.L. The clinical and electrophysiological features of a delayed polyneuropathy developing subsequently after acute organophosphate poisoning and its correlation with the serum acetylcholinesterase. Electromyogr Clin Neurophysiol 43 (2003) 421-427
21. Baker D.J., and Sedgwick M.E. Single fibre electromyographic changes in man after organophosphate exposure. Hum Exp Toxicol 15 (1996) 369-375
22. Bardin P.G., Van Eeden S.F., and Joubert J.R. Intensive care management of acute organophosphate poisoning. A 7-year experience in the western Cape. S Afr Med J 72 (1987) 593-597
23. Benslama A., and Moutaouakkil S. Syndrome intermédiaire lors d'une intoxication aigue par la malathion. Presse Méd 27 (1998) 713-715
24. Benson B., Tolo D., and McIntire M. Is the intermediate syndrome in organophosphate poisoning the result of insufficient oxime therapy?. Clin Toxicol 30 (1992) 347-349
25. Besser R., Gutmann L., Dillmann U., et al. End-plate dysfunction in acute organophosphate intoxication. Neurology 39 (1989) 561-567
26. Besser R., Gutmann L., and Weilemann L.S. Inactivation of end-plate acetylcholinesterase during the course of organophosphate intoxications. Arch Toxicol 63 (1989) 412-415
27. Besser R., Vogt T., Gutmann L., et al. Impaired neuromuscular transmission during partial inhibition of acetylcholinesterase: the role of stimulus-induced backfiring in the generation of the decrement-increment phenomenon. Muscle Nerve 15 (1992) 1072-1080
28. Besser R., Weilemann L.S., and Gutmann L. Efficacy of obidoxime in human organophosphorus poisoning: determination by neuromuscular transmission studies. Muscle Nerve 18 (1995) 15-22
29. Betrosian A., Balla M., Kafiri G., et al. Multiple systems organ failure from organophosphate poisoning. Clin Toxicol 33 (1995) 257-260
30. Bidstrup P.L., Bonnell J.A., and Beckett A.G. Paralysis following poisoning by a new organic phosphorus insecticide (Mipafox): report on two cases. Br Med J 1 (1953) 1068-1072
31. Bismuth C., Inns R.H., and Marrs T.C. Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: Ballantyne B., and Marrs T.C. (Eds). Clinical and Experimental Toxicology of Organophosphates and Carbamates (1992), Butterworth-Heinemann, Oxford 555-577
32. Bouldin T.W., and Cavanagh J.B. A fine-structural study of the early stages of axonal degeneration. Am J Pathol 94 (1979) 253-270
33. Bouldin T.W., and Cavanagh J.B. A teased-fiber study of the spatio-temporal spread of axonal degeneration. Am J Pathol 94 (1979) 241-251
34. Bowman W.C., Gibb A.S., Harvey A.C., et al. Prejunctional actions of cholinoceptor agonists, and of anticholinesterase drugs. In: Kharkevic D.A. (Ed). New Neuromuscular Blocking Agents (1986), Springer-Verlag, Berlin, Heidelberg, New York 141-170
35. Brahmi N., Gueye P.N., Thabet H., et al. Extrapyramidal syndrome as a delayed and reversible complication of acute dichlorvos organophosphate poisoning. Vet Hum Toxicol 46 (2004) 187-203
36. Brimblecombe R.W., Green D.M., Stratton J.A., et al. The protective actions of some anticholinesterase drugs in sarin poisoning. Br J Pharmacol 9 (1970) 822-830
37. Bryk B., Moyal-Segal L.B., Podoly E., et al. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities. J Neurochem 92 (2005) 1216-1227
38. Buckley N.A., Roberts D., and Eddleston M. Overcoming apathy in research on organophosphate poisoning. Br Med J 329 (2004) 1231-1233
39. Buckley N.A., Eddleston M., and Szinicz L. Oximes for acute organophosphate pesticide poisoning. Cochrane Collaboration 2 (2005) 1-13
40. Capacio B.R., Byers C.E., Merk K.A., et al. Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman. Drug Chem Toxicol 27 (2005) 95-110
41. Casida J.E., and Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 17 (2004) 983-998
42. Cavanagh J.B. The significance of the "dying-back" process in experimental and human neurological disease. Int Rev Exp Path 3 (1964) 219
43. Chang C.C., Hong S.J., and Ko J.L. Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm. Br J Pharmacol 87 (1986) 757-762
44. Chaudhuri J., Chakraborti T.K., Chanda S., et al. Differential modulation of organophosphate-sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos. J Biochem Toxicol 8 (1993) 207-216
45. Choi P., and Quinonez L. The use of glycopyrrolate in a case of intermediate syndrome following acute organophosphate poisoning. Can J Anaesth 45 (1998) 337-340
46. Chuang C.C., Lin T.S., and Tsai M.C. Delayed neuropathy and myelopathy after organophosphate intoxication. N Engl J Med 347 (2002) 1119-1121
47. Clarman M., and Geldmacher-von Mallinckradt M. Über eine erfolgreich behandelte akute orale Vergiftung durch Fenthion und dessen Nachweis in Mageninhalt und Harn. Archiv Für Toxikol 22 (1966) 2-11
48. Clinton M.E., and Dettbarn W. Prevention of phospholine-induced myopathy with d-tubocurarine, atropine sulfate, diazepam, and creatine phosphate. J Toxicol Environ Health 21 (1987) 435-444
49. Costa L.G., McDonald B.E., Murphy S.D., et al. Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats. Toxicol Appl Pharmacol 103 (1990) 66-76
50. Costa L.G., Cole T.B., and Furlong C.E. Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates. J Toxicol Clin Toxicol 41 (2003) 37-45
51. Costa L.G., Cole T.B., Jarvik G.P., et al. Functional genomics of the paraoxonase (PON1) polymorphisms: effect on pesticide sensitivity, cardiovascular disease and drug metabolism. Annu Rev Med 54 (2003) 371-392
52. Costa L.G., Cole T.B., Vitalone A., et al. Measurement of paraoxonase (PON1) status as potential biomarker of susceptibility to organophosphate toxicity. Clin Chem Acta 352 (2005) 37-47
53. Cousin X., Strahle U., and Chatonnet A. Are there non-catalytic functions of acetylcholinesterases? Lessons from mutant animal models. Bioassays 27 (2005) 189-200
54. Cygler M., Schrag J.D., Sussman J.L., et al. Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related enzymes. Protein Sci 2 (1993) 366-382
55. Davies J.E., Barquet A., Freed V.H., et al. Human pesticide poisonings by a fat-soluble organophosphate insecticide. Arch Environ Health 30 (1975) 608-613
56. Davis L.E., Eisen A., Murphy F.M., et al. Clinical and laboratory assessment of distal peripheral nerves in Gulf War veterans and spouses. Neurology 63 (2004) 1070-1077
57. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14 (1994) 317-331
58. de Blaquiere G.E., Waters L., Blain P., et al. Electrophysiological and biochemical effects of single and multiple doses of the organophosphate Diazinon in the mouse. Toxicol Appl Pharmacol 166 (2000) 81-91
59. De Bleecker J.L. Transient opsoclonus in organophosphate poisoning. Acta Neurol Scand 86 (1992) 529-531
60. De Bleecker J., Willems J., De Reuck J., et al. Histological and histochemical study of paraoxon myopathy in the rat. Acta Neurol Belg 91 (1991) 255-270
61. De Bleecker J., Van Den Neucker K., and Willems J. The intermediate syndrome in organophosphate poisoning: presentation of a case and review of the literature. Clin Toxicol 30 (1992) 321-329
62. De Bleecker J., Vogelaers D., Ceuterick C., et al. Intermediate syndrome due to prolonged parathion poisoning. Acta Neurol Scand 86 (1992) 421-424
63. De Bleecker J., Willems J., Van Den Neucker K., et al. Prolonged toxicity with intermediate syndrome after combined parathion and methyl parathion poisoning. Clin Toxicol 30 (1992) 333-345
64. De Bleecker J.L., De Reuck J.L., and Willems J.L. Neurological aspects of organophosphate poisoning. Clin Neurol Neurosurg 94 (1992) 93-103
65. De Bleecker J.L., Van Den Abeele K.G., and De Reuck J.L. Variable involvement of rat skeletal muscles in paraoxon-induced necrotizing myopathy. Res Commun Pathol Pharmacol 75 (1992) 309-322
66. De Bleecker J., Van Den Neucker K., and Colardyn F. Intermediate syndrome in organophosphorus poisoning: a prospective study. Crit Care Med 21 (1993) 1706-1711
67. De Bleecker J., Lison D., Van Den Abeele K., et al. Acute and subacute organophosphate poisoning in the rat. Neurotoxicol 15 (1994) 341-348
68. De Bleecker J.L., Van Den Abeele K.G., and De Reuck J.L. Electromyography in relation to end-plate acetylcholinesterase in rats poisoned by different organophosphates. Neurotoxicol 15 (1994) 331-340
69. De Bleecker J.L., Meire V.I., and Pappens S. Quinidine prevents paraoxon-induced necrotizing myopathy in rats. Neurotoxicol 19 (1998) 833-838
70. de Clermont P. Note sur la préparation de quelques éthers (Séance du lundi 14 août 1854). C R 39 (1854) 338-340
71. de Clermont P. Mémoire sur les éthers phosphoriques. Ann Chim Phys 44 (1855) 330-336
72. de Jager A.E., van Weerden T.W., Houthoff H.J., et al. Polyneuropathy after massive exposure to parathion. Neurology 31 (1981) 603-605
73. De Kort W., Savelkoul T.F.J., Sindram J.W., et al. "Delayed neurotoxicity" na intoxicatie met organofosforverbindingen. Ned Tijdschr Geneeskd 130 (1986) 1896-1898
74. De Reuck J., and Willems J. Acute parathion poisoning: myopathic changes in the diaphragm. J Neurol 208 (1975) 309-314
75. De Reuck J., Colardyn F., and Willems J. Fatal encephalopathy in acute poisoning with organophosphorus insecticides. A clinico-pathologic study of two cases. Clin Neurol Neurosurg 81 (1979) 247-254
76. De Silva H.J., Wijewickrema R., and Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning?. Lancet 339 (1992) 1136-1138
77. De Wilde V., Vogelaers D., Colardyn F., et al. Postsynaptic neuromuscular dysfunction in organophosphate induced intermediate syndrome. Klin Wochenschr 69 (1991) 177-183
78. Dean G., Coxon J., and Brereton D. Poisoning by an organophosphorus compound: a case report. S A Med J 41 (1967) 1017-1019
79. Deana A., and Scuka M. Time course of neostigmine action on the endplate response. Neurosci Lett 118 (1990) 82-84
80. Dekleva A., Sket D., Sketelj J., et al. Attenuation of soman-induced lesions of skeletal muscle by acetylcholinesterase reactivating and non-reactivating antidotes. Acta Neuropathol 79 (1989) 183-189
81. Dettbarn W. Pesticide induced muscle necrosis: mechanisms and prevention. Fund Appl Toxicol 4 (1984) S18-S26
82. Dickoff D.J., Gerber O., and Turovsky Z. Delayed neurotoxicity after ingestion of carbamate pesticide. Neurology 37 (1987) 1229-1231
83. Dive A., Mathieu R., Van Binst R., et al. Unusual manifestations after malathion poisoning. Hum Exp Toxicol 13 (1994) 271-274
84. Dongren Y., Tao L., and Fengsheng H. Electroneurophysiological studies in rats of acute dimethoate poisoning. Toxicol Lett 107 (1999) 249-254
85. DuToit P.W., Muller F.O., van Tonder W.M., et al. Experience with the intensive care management of organophosphate insecticide poisoning. S Afr Med J 60 (1981) 227-229
86. Duysen E.G., Li B., Xie W., et al. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J Pharmacol Exp Ther 299 (2001) 528-535
87. Eccles J.C., and McFarlane W.V. Actions of anticholinesterase on end plate potential of frog muscle. J Neurophysiol 12 (1949) 59
88. Eddleston M., Karalliedde L., Buckley N., et al. Pesticide poisoning in the developing world-a minimum pesticide list. Lancet 360 (2002) 1163-1167
89. Eddleston M., Szinicz L., Eyer P., et al. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM 95 (2002) 275-283
90. Ellman G.L., Courtney K.D., Andres V., et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7 (1961) 88-95
91. Engel A.G., Lambert E.H., and Gomez M.R. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol 1 (1977) 315-330
92. Evans R.T. Cholinesterase phenotyping: clinical aspects and laboratory applications. CRC Crit Rev Clin Lab Sci 23 (1986) 35-64
93. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 22 (2003) 165-190
94. Fenichel G.M., Kibler W.B., Olson W.H., et al. Chronic inhibition of cholinesterase as a cause of myopathy. Neurology 22 (1972) 1026-1033
95. Fenichel G.M., Dettbarn W., and Newman T.M. An experimental myopathy secondary to excessive acetylcholine release. Neurology 24 (1974) 41-45
96. Fenichel G.M., Kibler W.B., and Dettbarn W. The effects of immobilization and exercise on acetylcholine-mediated myopathies. Neurology 24 (1974) 1086-1090
97. Fenthon J.C.B. The nature of the paralysis in chickens following organophosphorus poisoning. J Pathol Bacteriol 69 (1955) 181-189
98. Firemark H., Barlow C.F., and Roth L.J. The penetration of 2-PAMCl into brain and the effects of cholinesterase inhibitors on its transport. J Pharmacol Exp Ther 145 (1964) 252-265
99. Food and Agriculture Organization/World Health Organization. Pesticide Residues in Food: 1992 Evaluations. Part II-Toxicology (1993), World Health Organization, Geneva WHO/PCS/93.34
100. Food and Agriculture Organization/World Health Organization. Pesticide Residues in Food: 1993 Evaluations. Part II-Toxicology (1994), World Health Organization, Geneva WHO/PCS/94.4
101. Forbat J.N., and Skehan J.D. Health effects of organophosphate sheep dips. Br Med J 305 (1992) 1503
102. Frederikssons T. Pharmacological properties of methyl-fluorophosphoryl cholines. Two synthetic cholinergic drugs. Arch Int Pharmacodyn 113 (1957) 101-113
103. Frederikssons T. Further studies on fluoro-phosphorylcholines. Pharmacological properties of two new analogues. Arch Int Pharmacodyn 115 (1958) 474-482
104. Froede H.C., and Wilson I.B. Direct determination of acetyl-enzyme intermediate in the acetylcholinesterase-catalyzed hydrolysis of acetylcholine and acetylthiocholine. J Cell Biochem 259 (1984) 11010-11013
105. Gadoth N., and Fisher A. Late onset of neuromuscular block in organophosphorus poisoning. Ann Intern Med 88 (1978) 654-655
106. Gan K.N., Smolen A.L., Eckerson H.W., et al. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 19 (1991) 100-106
107. Glynn P. Neuropathy target esterase. Biochem J 344 (1999) 625-631
108. Gordon J.J., Leadbeater L., and Maidment M.P. The protection of animals against organophosphate poisoning by pre-treatment with a carbamate. Toxicol Appl Pharmacol 43 (1978) 207-216
109. Grob D. Anticholinesterase intoxication in man and its treatment. In: Koelle G.B. (Ed). Cholinesterases and Anticholinesterase Agents (1963), Springer-Verlag, Berlin, Gottingen, Heidelberg 989-1027
110. Guadarrama-Naveda M., de Cabrera L.C., and Matos-Bastidas S. Intermediate syndrome secondary to ingestion of chlorpiriphos. Vet Hum Toxicol 43 (2001) 34
111. Gupta A., Agarwal R., and Shukla G.S. Functional impairment of blood-brain barrier following pesticide exposure during early development in rats. Hum Exp Toxicol 18 (1999) 174-179
112. Gupta R.C., Patterson G., and Dettbarn W. Mechanisms of toxicity and tolerance to diisopropylphosphorofluoridate at the neuromuscular junction of the rat. Toxicol Appl Pharmacol 84 (1986) 541-550
113. Haley R.W. Excess incidence of ALS in young Gulf War veterans. Neurology 61 (2003) 750-756
114. Haley R.W., Hom J., Roland P.S., et al. Evaluation of neurologic function in Gulf War veterans. A blinded case-control study. JAMA 277 (1997) 223-230
115. Haley R.W., Kurt T.L., and Horn J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 277 (1997) 215-222
116. Harel M., Sussman J.L., Krejci E., et al. Conversion of acetylcholinesterase to butyrylcholinesterase, modeling and mutagenesis. Proc Natl Acad Sci USA 89 (1992) 10827-10831
117. Harris L.W., Talbot B.G., Lennox W.J., et al. The relationship between oxime-induced reactivation of carbamylated acetylcholinesterase and antidotal efficacy against carbamate intoxication. Toxicol Appl Pharmacol 98 (1989) 128-133
118. Hasin Y., Avidan N., Bercovich D., et al. A paradigm for single nucleotide polymorphism analysis: the case of the acetylcholinesterase gene. Hum Mutat 24 (2004) 408-416
119. Hata S., Bernstein E., and Davis L.E. Atypical ocular bobbing in acute organophosphate poisoning. Arch Neurol 43 (1986) 185-186
120. He F., Xu H., Qin F., et al. Intermediate myasthenia syndrome following acute organophosphates poisoning-an analysis of 21 cases. Hum Exp Toxicol 17 (1998) 40-45
121. Hena S., and Finkelman J. De plaguicidas y salud en las Americas (1993), Centro Panamericano de Ecologia Humana y Salud, Mexico
122. Hierons R., and Johnson M.K. Clinical and toxicological investigation of a case of delayed neuropathy in man after acute poisoning by an organophosphorus pesticide. Arch Toxicol 40 (1978) 279-284
123. Hobbiger F. Reactivation of phosphorylated AChE. Handbuch der Experimentellen Pharmakologie (1963), Springer-Verlag, Berlin 921-988
124. Horner R.D., Kamins K.G., Feussner J.R., et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 61 (2003) 742-749
125. Hudson C.S., and Foster R.E. Presynaptic effects of pyridostigmine on the neuro-muscular junction of the rat diaphragm. J Cell Biochem 99 (1984) 29
126. Hudson C.S., Foster R.E., and Kahng M.W. Neuromuscular toxicity of pyridostigmine-bromide in the diaphragm, extensor digitorum longus, and soleus muscles of the rat. Fund Appl Toxicol 5 (1985) 260-269
127. Idriss M.K., Aguayo L.G., Rickett D.L., et al. Organophosphate and carbamate compounds have pre- and postjunctional effects at the insect glutamatergic synapse. J Pharmacol Exp Ther 239 (1986) 279-285
128. Inns R.H., and Marrs T.C. Prophylaxis against anticholinesterase poisoning. In: Ballantyne B., and Marrs T.C. (Eds). Clinical and Experimental Toxicology of Organophosphates and Carbamates (1992), Butterworth-Heinemann, Oxford 602-610
129. Inns R.H., Tuckwell N.J., Bright J.E., et al. Histochemical demonstration of calcium accumulation in muscle fibres after experimental organophosphate poisoning. Hum Exp Toxicol 9 (1990) 245-250
130. Inoue N., Fujishiro K., Mori K., et al. Triorthocresyl phosphate poisoning. A review of human cases. J UOEH 10 (1988) 433-442
131. Jedrzejowska H., Rowinska-Marcinska K., and Hoppe B. Neuropathy due to phytosol (Agritox). Report of a case. Acta Neuropathol 49 (1980) 163-168
132. Jett D.A., Navoa R.V., Beckles R.A., et al. Cognitive function and cholinergic neurochemistry in weanling rats exposed to chlorpyrifos. Toxicol Appl Pharmacol 174 (2001) 89-98
133. Jeyaratnam J., De Alwis Senewiratne R.S., and Copplestone J.F. Survey of pesticide poisoning in Sri Lanka. Bulletin of the World Health Organisation 60 (1982) 615-619
134. Johnson M.K. The delayed neuropathy caused by some organophosphate esters: mechanisms and challenge. Crit Rev Toxicol 3 (1975) 289-316
135. Johnson M.K. Organophosphates and delayed neuropathy. Is NTE alive and well?. Toxicol Appl Pharmacol 102 (1990) 385-399
136. Jortner B.S., Hancock S.K., Hinckley J., et al. Neuropathological studies of rats following multiple exposure to tri-ortho-tolyl phosphate, chlorpyrifos and stress. Toxicol Pathol 33 (2005) 378-385
137. Joubert J., and Joubert P.H. Chorea and psychiatric changes in organophosphate poisoning. S Afr Med J 74 (1988) 32-34
138. Joubert J., Joubert P.H., van der Spuy M., et al. Acute organophosphate poisoning presenting with choreoathetosis. J Toxicol Clin Toxicol 22 (1984) 187-191
139. Karademir M., Ertürk F., and Koçak R. Two cases of organophosphate poisoning with development of intermediate syndrome. Hum Exp Toxicol 9 (1990) 187-189
140. Karalliedde L., and Szinicz L. Management of organophosphorus compound poisoning. In: Karalliedde L., Feldman S., and Henry J. (Eds). Organophosphates and Health (2001), Imperial College Press, London 257-293
141. Karalliedde L., Senanayake N., and Ariaratnam A. Acute organophosphorus insecticide poisoning during pregnancy. Hum Toxicol 7 (1988) 363-364
142. Kawabuchi M., Boyne A.F., Deshpande S.S., et al. Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation. Synapse 2 (1988) 139-147
143. Kawabuchi M., Boyne A.F., Desphande A.F., et al. The reversible carbamate, (-)physostigmine, reduces the size of synaptic end plate lesions induced by sarin, an irreversible organophosphate. Toxicol Appl Pharmacol 97 (1989) 98-106
144. Kiderlen D., Worek F., Klimmek R., et al. The phosphoryl oxime-destroying activity of human plasma. Arch Toxicol 74 (2000) 27-32
145. Kilby B.A., and Kilby M. The toxicity of alkyl fluorophosphorates in man and animals. Br J Pharmacol 2 (1947) 234-240
146. Kovarik Z., Radic Z., Berman H.A., et al. Acetylcholinesterase active centre and gorge conformations analysed by combination mutations and enantiomeric phosphonates. Biochem J 373 (2003) 33-40
147. Kusic R., Jovanovic D., Randjelovic S., et al. HI-6 in man: efficacy of the oxime in poisoning by organophosphorus insecticides. Hum Exp Toxicol 10 (1991) 113-118
148. Lai M.W., and Moen M. Pesticide-like poisoning from a prescription drug. N Engl J Med 353 (2005) 317-318
149. Laskowski M.B., and Dettbarn W. An electrophysiological analysis of the effects of paraoxon at the neuromuscular junction. J Pharmacol Exp Ther 210 (1979) 269-274
150. Lekeux P., Kyavu A., Clercx C., et al. Pulmonary function changes induced by experimental dichlorvos toxicosis in calves. Res Vet Sci 40 (1986) 318-321
151. Leonard J.P., and Salpeter M.M. Agonist-induced myopathy at the neuromuscular junction is mediated by calcium. J Cell Biol 82 (1979) 811-819
152. Li B., Stribley J.A., Ticu A., et al. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 75 (2000) 1320-1331
153. Lockridge O., and Masson P. Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk. Neurotoxicology 21 (2000) 113-126
154. Lockridge O., Duysen E.G., Voelker T., et al. Life without acetylcholinesterase: the implications of cholinesterase inhibitor toxicity in AChE-knockout mice. Environ Toxicol Pharmacol 19 (2005) 463-469
155. Loewenstein-Lichtenstein Y., Schwartz M., Glick D., et al. Genetic predisposition to adverse conditions of anti-cholinesterases in "atypical" BCHE. Nature Med 1 (1995) 1082-1085
156. Lotti M. The pathogenesis of organophosphate delayed polyneuropathy. Crit Rev Toxicol 21 (1992) 465-487
157. Lotti M., and Johnson M.K. Neurotoxicity of organophosphorus pesticides: predictions can be based on in vitro studies with hen and human enzymes. Arch Toxicol 41 (1978) 215-221
158. Lotti M., and Moretto A. Organophosphate induced delayed polyneuropathy. Toxicol Rev 24 (2005) 37-49
159. Lotti M., Becker C.E., and Aminoff M.J. Organophosphate polyneuropathy: pathogenesis and prevention. Neurology 34 (1984) 658-662
160. Lotti M., Moretto A., Zoppellari R., et al. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch Toxicol 59 (1986) 176-179
161. Lotti M., Moretto A., Capodicasa E., et al. Interaction between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol Appl Pharmacol 122 (1993) 165-171
162. Luo C., Ashani Y., and Doctor B.P. Acceleration of oxime-induced reactivation of organophosphate-inhibited fetal bovine serum acetylcholinesterase by monoquaternary and bisquaternary ligands. Mol Pharmacol 53 (1998) 718-726
163. Luo C., Saxena A., Smith M., et al. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium. Biochemistry 38 (1999) 9937-9947
164. Mackerer C.R., Barth M.L., Krueger A.J., et al. Comparison of neurotoxic effects and potential risks from oral administration or ingestion of tricresyl phosphate and jet engine oil containing tricresyl phosphate. J Toxicol Environ Health 57 (1999) 293-328
165. Mahieu P., Hassoun A., Van Binst R., et al. Severe and prolonged poisoning by fenthion. Significance of the determination of the anticholinesterase capacity of plasma. Clin Toxicol 19 (1982) 425-432
166. Marrs T.C. Organophosphate poisoning. Pharmacol Ther 58 (1993) 51-66
167. Martinez-Chuecos J., Jurado M.C., Gimenez M.P., et al. Experience with hemoperfusion for organophosphate poisoning. Crit Care Med 20 (1992) 1538-1543
168. Maselli R.A., and Soliven B.C. Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: paradoxical response to edrophonium and D-tubocurarine. Muscle Nerve 14 (1991) 1182-1188
169. Mason H.J. The recovery of plasma cholinesterase and erythrocyte acetylcholinesterase activity in workers after overexposure to dichlorvos. Occup Med 50 (2000) 343-347
170. Mason H.J., Sains C., Stevenson A.J., et al. Rates of spontaneous reactivation and aging of acetylcholinesterase in human erythrocytes after inhibition by organophosphorus pesticides. Human Exp Toxicol 19 (2000) 511-516
171. Maxwell D.M., Lenz D.E., Groff W.A., et al. The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats. Toxicol Appl Pharmacol 88 (1987) 66-76
172. McCain W.C., Lee R., Johnson M.S., et al. Acute oral toxicity study of pyridostigmine bromide, permethrin and DEET in the laboratory rat. J Toxicol Environ Health 50 (1997) 113-124
173. McConnell R., Delgado-Tellez E., Caudra R., et al. Organophosphate neuropathy due to methamidophos: biochemical and neurophysiological markers. Arch Toxicol 73 (1999) 296-300
174. Meshul C.K., Boyne A.F., Deshpande S.S., et al. Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor muscles. Exp Neurol 89 (1985) 96-114
175. Meshul C.K., Kriho V., Kriho N., et al. Calcium channel blocker influences the density of alpha-actinin labelling at the rat neuromuscular junction. Muscle Nerve 13 (1990) 348-354
176. Molphy R., and Rathus E.M. Organic phosphorus poisoning and therapy. Med J Aust 2 (1964) 337-340
177. Moretto A. Testing for organophosphate delayed polyneuropathy. In: Maines M.D., Costa L.G., Reed D.J., et al. (Eds). Current Protocols in Toxicology (1999), Wiley, New York 11.5.1-11.5.14
178. Moretto A., and Lotti M. Poisoning by organophosphorus insecticides and sensory neuropathy. J Neurol Neurosurg Psychiatry 64 (1998) 464-468
179. Moretto A., Lotti M., Sabri M.I., et al. Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy. J Neurochem 49 (1987) 1515-1522
180. Moretto A., Capodicasa E., Peraica M., et al. Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks. Biochem Pharmacol 41 (1991) 1497-1504
181. Moretto A., Capodicasa E., and Lotti M. Clinical expression of organophosphate-induced delayed polyneuropathy in rats. Toxicol Lett 63 (1992) 97-102
182. Morgan J.P., and Petrovich P. Jamaica ginger paralysis. Forty-seven-year follow-up. Arch Neurol 35 (1978) 530-532
183. Moser V.C. Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats. Neurotoxicol Teratol 17 (1995) 617-625
184. Nagata K., Huang C., Song J., et al. Direct actions of anticholinesterases on the neuronal nicotinic acetylcholine receptor channels. Brain Res 769 (1997) 211-218
185. Namba T., Nolte C.T., Jackrel J., et al. Poisoning due to organophosphate insecticides. Am J Med 50 (1971) 475-492
186. Newmark J. Therapy for nerve agent poisoning. Arch Neurol 61 (2004) 649-651
187. Nisse P., Forceville X., Cezard C.C., et al. Intermediate syndrome with delayed distal polyneuropathy from ethyl parathion poisoning. Vet Hum Toxicol 40 (1998) 166-168
188. Norman J. Neuromuscular blockade. In: Aitkenhead A.R., and Smith G. (Eds). A Textbook of Anaesthesia (1990), Churchill Livingstone, London 211-224
189. Ohno K., Brengman J.M., Tsujino A., et al. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci USA 95 (1998) 9654-9659
190. Okumura A., Kato T., Hayakawa F., et al. Non-epileptic pedaling-like movement induced by triclofos. Brain Dev 26 (2004) 487-489
191. Ordentlich A., Barak D., Kronman C., et al. The architecture of human acetylcholinesterase active center probed by interactions with selected organophosphate inhibitors. J Biol Chem 271 (1996) 11953-11962
192. Ordentlich A., Barak D., Kronman C., et al. Functional characteristics of the oxyanion hole in human acetylcholinesterase. J Biol Chem 273 (1998) 19509-19517
193. Ordentlich A., Barak D., Sod-Moriah G., et al. Stereoselectivity toward VX is determined by interactions with residues of the acyl pocket as well as of the peripheral anionic site of AChE. Biochemistry 43 (2004) 11255-11265
194. Peeples E.S., Schopfer L.M., Duysen E.G., et al. Albumine, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol Sci 83 (2005) 303-312
195. Perron R., and Johnson B.B. Insecticide poisoning. N Engl J Med 281 (1969) 274-275
196. Petroianu G.A., Missler A., Zuleger K., et al. Enzyme reactivator treatment in organophosphate exposure: clinical relevance of thiocholinesteratic activity of pralidoxime. Appl Toxicol 24 (2004) 429-435
197. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity?. J Toxicol Environ Health B Crit Rev 2 (1999) 161-181
198. Prineas J. The pathogenesis of dying-back polyneuropathies. Part I. An ultrastructural study of experimental tri-ortho-cresyl phosphate intoxication in the cat. J Neuropathol Exp Neurol 28 (1969) 571-597
199. Prody C.A., Dreyfus P., Zamir R., et al. De novo amplification within a "silent" human cholinesterase gene in a family subjected to prolonged exposure to organophosphorous insecticides. Proc Natl Acad Sci USA 86 (1989) 690-694
200. Quinn D.M. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem Rev 87 (1987) 955-979
201. Rantanen J., Lehtinen S., and Savolainen K. The opportunities and obstacles to collaboration between the developing and developed countries in the field of occupational health. Toxicology 198 (2004) 63-74
202. Richards P., Johnson M., Ray D., et al. Novel protein targets for organophosphorus compounds. Chem-Biol Interact (1999) 119-120 503-511
203. Rose M.R. Gulf War service is an uncertain trigger for ALS. Neurology 61 (2003) 730-731
204. Rose M.R., Sharief M.K., Priddin J., et al. Evaluation of neuromuscular symptoms in UK Gulf War veterans. Neurology 63 (2004) 1681-1687
205. Rousseaux C.G., and Dua A.K. Pharmacology of HI-6, an H-series oxime. Can J Physiol Pharmacol 67 (1989) 1183-1189
206. Sanderson D.M. Treatment of poisoning by anticholinesterase insecticides in the rat. J Pharm Pharmacol 13 (1961) 435-442
207. Sedgwick M.E., and Senanayake N. Pathophysiology of the intermediate syndrome of organophosphorus poisoning. J Neurol Neurosurg Psychiatry 62 (1997) 201-202
208. Senanayake N. Tri-cresyl phosphate neuropathy in Sri Lanka: a clinical and neurophysiological study with a three year follow up. J Neurol Neurosurg Psychiatry 44 (1981) 775-780
209. Senanayake N. Organophosphorus insecticide poisoning. Ceylon Med J 43 (1998) 22-29
210. Senanayake N., and Johnson M.K. Acute polyneuropathy after poisoning by a new organophosphate insecticide. N Engl J Med 306 (1982) 155-157
211. Senanayake N., and Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 316 (1987) 761-763
212. Senanayake N., and Sanmuganathan P.S. Extrapyramidal manifestations complicating organophosphorus insecticide poisoning. Hum Exp Toxicol 14 (1995) 600-604
213. Sevim S., Aktekin M., Dogu O., et al. Late onset polyneuropathy due to organophosphate (DDVP) intoxication. Can J Neurol Sci 30 (2003) 75-78
214. Sharief M.K., Priddin J., Delamont R.S., et al. Neurophysiologic analysis of neuromuscular symptoms in UK Gulf War veterans. Neurology 59 (2002) 1518-1525
215. Shaw K., Aracava Y., Akaike A., et al. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol Pharmacol 28 (1985) 527-538
216. Shiraishi S., Inoue N., Murai Y., et al. Dipterex (trichlorfon) poisoning-clinical and pathological studies in human and monkeys. J UOEH Suppl 5 (1983) 125-132
217. Singh G., Avasthi G., and Khurana D. Neurophysiological monitoring of pharmacological manipulation in acute organophosphate poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium. Electroencephalogr Clin Neurophysiol 107 (1998) 140-148
218. Singh G., Mahajan R., and Whig J. The importance of electrodiagnostic studies in acute organophosphate poisoning. J Neurol Sci 157 (1998) 191-200
219. Smith D.M. Organophosphorus poisoning from emergency use of a handsprayer. Practitioner 218 (1977) 877-883
220. Smulders C., Bueters T., Vailati S., et al. Block of neuronal nicotinic acetylcholine receptors by organophosphate insecticides. Toxicol Sci 82 (2004) 545-554
221. Soreq H., and Seidman S. Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2 (2001) 294-301
222. Spencer P.S., McCauley L.A., Lapidus J.A., et al. Self-reported exposures and their association with unexplained illness in a population-based case-control study of Gulf War veterans. J Occup Environ Med 43 (2001) 1041-1056
223. Stephens R., Spurgeon A., Calvert I.A., et al. Neuropsychological effects of long-term exposure to organophosphates in sheep dip. Lancet 345 (1995) 1135-1139
224. Sudakin D.L., Mullins M.E., Horowitz B.Z., et al. Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 38 (2000) 47-50
225. Susser M., and Stein Z. An outbreak of tri-ortho-cresyl phosphate (T.O.C.P.) poisoning in Durban. Br J Ind Med 14 (1957) 111-120
226. Suzuki T., Morita H., Ono K., et al. Sarin poisoning in Tokyo subway. Lancet 345 (1995) 980
227. Talbot B.G., Anderson D.R., Harris L.W., et al. A comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species. Drug Chem Toxicol 11 (1988) 289-305
228. Taylor P. Anticholinesterase agents. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's the Pharmacological Basis of Therapeutics (2001), McGraw-Hill, New York 175-191
229. Thiermann H., Mast U., Klimmek R., et al. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum Exp Toxicol 16 (1997) 473-480
230. Thiermann H., Szinicz L., Eyer F., et al. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett 107 (1999) 233-239
231. Tracy J.A., and Gallagher H. Use of glycopyrrolate and atropine in acute organophosphorus poisoning. Hum Exp Toxicol 9 (1990) 99-100
232. Tush G.M., and Anstead M.I. Pralidoxime continuous infusion in the treatment of organophosphate poisoning. Ann Pharmacother 31 (1997) 441-444
233. Umehara F., Izumo S., Arimura K., et al. Polyneuropathy induced by m-tolyl methyl carbamate intoxication. J Neurol 238 (1991) 47-48
234. Van Dijk J.G., Lammers G.J., Wintzen A.R., et al. Repetitive CMAPs: mechanisms of neural and synaptic genesis. Muscle Nerve 19 (1996) 1127-1133
235. van Helden H.P.M., Busker R.W., Melchers B.P.C., et al. Pharmacological effects of oximes: how relevant are they?. Arch Toxicol 70 (1996) 779-786
236. Vasconcellos L.F., Leite A.C., and Nascimento O.M. Organophosphate-induced delayed neuropathy. Arq Neuropsiquiatr 60 (2002) 1003-1007
237. Vasilescu C., and Florescu A. Clinical and electrophysiological study of neuropathy after organophosphorus compounds poisoning. Arch Toxicol 43 (1980) 305-315
238. Vasilescu C., Alexianu M., and Dan A. Delayed neuropathy after organophosphorus insecticide (Dipterex) poisoning: a clinical, electrophysiological and nerve biopsy study. J Neurol Neurosurg Psychiatry 47 (1984) 543-548
239. Veronesi B. A rodent model of organophosphorus-induced delayed neuropathy: distribution of central (spinal cord) and peripheral nerve damage. Neuropathol Appl Neurobiol 10 (1984) 357-368
240. Wadia R.S., Sadagopan C., Amin R.B., et al. Neurological manifestations of organophosphorus insecticide poisoning. J Neurol Neurosurg Psychiatry 37 (1974) 841-847
241. Walsh C. Enzymatic Reaction Mechanisms (1979), Freeman, San Francisco
242. Wecker L., Kiauta T., and Dettbarn W. Relationship between acetylcholinesterase inhibition and the development of a myopathy. J Pharmacol Exp Ther 206 (1978) 97-104
243. Wecker L., Laskowski M.B., and Dettbarn W. Neuromuscular dysfunction induced by acetylcholinesterase inhibition. Fed Proc 37 (1978) 2818-2822
244. Wecker L., Mark R.E., and Dettbarn W. Evidence of necrosis in human intercostal muscle following inhalation of an organophosphate insecticide. J Environ Path Toxicol Oncol 6 (1985) 171-175
245. Wecker L., Mark R.E., and Dettbarn W. Evidence of necrosis in human intercostal muscle following inhalation of an organophosphate insecticide. Fundam Appl Toxicol 6 (1986) 172-174
246. Wehner J.M., Smolen A., Smolen T.N., et al. Recovery of acetylcholinesterase activity after acute organophosphate treatment of CNS reaggregate cultures. Fundam Appl Toxicol 5 (1985) 1104-1109
247. Weinbroum A.A. Pathophysiological and clinical aspects of combat anticholinesterase poisoning. Br Med Bull 72 (2005) 119-133
248. Weisskopf M.G., O'Reilly E.J., McCullough M.L., et al. Prospective study of military service and mortality from ALS. Neurology 64 (2005) 32-37
249. Whittaker M. Cholinesterase. In: Beckman L. (Ed). Monographs in Human Genetics Vol. 11 (1986), Karger, Basel
250. Willems J.L. Poisoning by organophosphate insecticides: analysis of 53 human cases with regard to management and drug treatment. Acta Med Milit Belg 134 (1981) 7-15
251. Willems J., and Belpaire F. Anticholinesterase poisoning: an overview of pharmacotherapy and clinical management. In: Ballantyne B., and Marrs T. (Eds). Clinical and Experimental Toxicology of Anticholinesterases (1991), Butterworths, Guildford 536-542
252. Willems J.L., and Belpaire F.M. Anticholinergic poisoning: an overview of pharmacotherapy. In: Ballantyne B., and Marrs T.C. (Eds). Clinical and Experimental Toxicology of Organophosphates and Carbamates (1992), Butterworth-Heinemann, Oxford 536-542
253. Willems J.L., Langenberg J.P., Verstraete A.G., et al. Plasma concentrations of pralidoxime methylsulphate in organophosphorus poisoned patients. Arch Toxicol 66 (1992) 260-266
254. Willems J.L., De Bisschop H.C., Verstraete A.G., et al. Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and of the organophosphate. Arch Toxicol 67 (1993) 79-84
255. Wilson B.H., Hooper M.J., Hansen M.E., et al. Reactivation of organophosphorus inhibited AChE with oximes. In: Chambers J.E., and Levi P.E. (Eds). Organophosphates-Chemistry, Fate and Effects (1992), Academic Press, San Diego 107-137
256. Wilson B.W. Cholinesterases. In: Krieger R.I. (Ed). Handbook of Pesticide Toxicology (2001), Academic Press, San Diego 967-985
257. Wilson I.B., and Ginsburg S. A powerful reactivator of alkyl phosphate-inhibited acetylcholinesterase. Biochem Biophys Acta 18 (1955) 168-170
258. Wong L., Radic Z., Bruggermann R.J.M., et al. Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis. Biochemistry 39 (2000) 5750-5757
259. Worek F., Kirchner T., Bäcker M., et al. Reactivation by various oximes of human erythrocytes acetylcholinesterase inhibited by different organophosphorus compounds. Arch Toxicol 70 (1996) 497-503
260. Worek F., Diepold C., and Eyer P. Dimethylphosphoryl-inhibited human cholinesterase: inhibition, reactivation, and aging kinetics. Arch Toxicol 73 (1999) 7-14
261. World Health Organization. Public Health Impact of Pesticides Used in Agriculture (1990), World Health Organization, Geneva
262. Xie W., Stribley J.A., Chatonnet A., et al. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J Pharmacol Exp Ther 293 (2000) 896-902
263. Yang P.Y., Tsao T., Lin J.L., et al. Carbofuran-induced delayed neuropathy. Clin Toxicol 38 (2000) 43-46
264. Zilker T., and Hibler A. Treatment of severe parathion poisoning: clinical aspects. In: Szinicz L., Eyer P., and Klimmek R. (Eds). Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning (1996), Spectrum Akademischer Verlag, Heidelberg 9-17
265. Zwiener R.J., and Ginsburg M. Organophosphate and carbamate poisoning in infants and children. Pediatrics 81 (1988) 121-126